LMAT LeMaitre Vascular, Inc.

75.92USD+1.42%Mkt Cap: 1.71B USDP/E: 27.22

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers al…

Institutional holders20 on file

Key Statistics

Company
Market Cap1.71B USD
Enterprise Value1.51B USD
Revenue (TTM)269.36M USD
Gross Profit178.54M USD
Net Income (TTM)57.73M USD
Revenue/Share11.81 USD
Last Price75.92 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees646
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)27.22
P/E (Forward)23.77
PEG2.00
EV/EBITDA19.57
EV/Revenue5.61
P/S6.36
P/B3.96
EPS (TTM)2.75 USD
EPS (Forward)3.15 USD
52W Range
73.685% of range118.01
52W High118.01 USD
52W Low73.68 USD
Profitability
Gross Margin71.53%
Oper. Margin24.69%
EBITDA Margin28.69%
Profit Margin23.13%
ROE14.67%
ROA9.38%
ROIC23.71%
ROCE11.72%
Growth
Revenue Growth11.30%
Earnings Growth-13.70%
Cash Flow & Leverage
Operating CF81.25M USD
CapEx (TTM)6.78M USD
FCF Margin15.98%
FCF Yield2.51%
Net Debt-200.87M USD
Net Debt/EBITDA-2.60
Net Debt/FCF-4.67
Balance Sheet
Debt/Equity0.47
Current Ratio14.60
Quick Ratio12.29
Book Value/Sh18.89 USD
Cash/Share17.03 USD
Dividends
Fwd Div Rate1.00 USD
Trail. Div Rate0.95 USD
Div. Yield1.32%
5Y Avg Yield0.88%
Payout Ratio34.55%
Ex-Div DateNov 19, 2026
Pay DateDec 3, 2026
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)99.29 USD
Upside (mean)+30.8%
Target Range81.00 USD – 132.00 USD
81.00+30.8% to mean132.00
# Analysts7
Ownership
Shares Out.22.88M
Float21.31M
Insiders6.52%
Institutions106.99%
Short Interest
Short Ratio6.1d
Short % Float9.10%
Short % Out.7.24%
Shares Short1.66M
Short (prev mo.)1.74M
Technical
SMA 5081.09 (-6.4%)
SMA 20094.08 (-19.3%)
Beta0.49
S&P 52W Chg12.00%
Avg Vol (30d)271.01K
Avg Vol (10d)255.09K
Technical Indicators
RSI (14)36.0
MACD-1.7758
MACD Signal-1.0133
MACD Hist.-0.7624
BB Upper87.81 USD
BB Middle80.74 USD
BB Lower73.66 USD
BB Width17.53%
ATR (14)2.521 USD
Vol Ratio (20d)0.89x

About LeMaitre Vascular (NASDAQ: LMAT)

›

LeMaitre Vascular (NASDAQ: LMAT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 646 employees.

The shares were at 75.92 USD on 20 November 2026, down 11.9% over 52 weeks. Its 52-week range is 73.68 USD to 118.01 USD: the price is 35.7% below the high and 3.0% above the low.

At a market capitalisation of 1.71B USD, it trades at 27.2 times trailing earnings and 23.8 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 45% for LMAT. It pays a dividend yielding 1.32% (it pays out 35% of its earnings), against a median of 0.92% among the dividend payers in that peer group.

LeMaitre Vascular reports return on equity of 14.7%, an operating margin of 24.7% and revenue up 11.3% year over year.

It holds more cash than debt, a net cash position of 200.87M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 99.29 USD is 30.8% above the current price. The next earnings report is expected on 24 February 2027.